STOCK TITAN

Mirion Technologies Inc. - MIR STOCK NEWS

Welcome to our dedicated news page for Mirion Technologies (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Mirion Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Mirion Technologies's position in the market.

Rhea-AI Summary
Mirion, a global provider of radiation detection solutions, announced the redemption of all publicly traded warrants to purchase shares of Class A common stock at a redemption price of $0.10 per warrant. The redemption date is set for May 20, 2024, with the stock price condition already met. Warrant holders can exercise their warrants until the redemption date, either for cash or on a cashless basis. The redemption process and contact information for inquiries are provided in the press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.18%
Tags
none
-
Rhea-AI Summary
Mirion (NYSE: MIR) will release its financial results for the first quarter of 2024 on April 30, 2024, followed by a conference call on May 1, 2024, to discuss the results. Participants can access the call via phone or webcast, with replays available until May 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
-
Rhea-AI Summary
Mirion (MIR) CEO to present at B. Riley Securities' Radiopharma Day in New York
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
conferences
Rhea-AI Summary
Mirion (MIR) CEO, Thomas Logan, to participate in SHARE Series fireside chat with Wolfe Research Analyst. Event on February 26, 2024, at 9:00 AM ET. Investors can submit questions online. Webcast live at https://www.openexchange.tv/monday-management-update-february-26th/mirion-technologies-inc-nyse-mir?category=1303. Archive available within twelve hours.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
conferences
-
Rhea-AI Summary
Mirion (MIR) reported a 5.7% revenue increase to $230.4 million in Q4, with a net loss improvement of 90.1% to $15.2 million. Adjusted EBITDA rose by 8.2% to $61.0 million. The company set 2024 guidance with revenue growth of 5% to 7%, adjusted EBITDA of $193 million to $203 million, and adjusted EPS of $0.37 to $0.42.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.69%
Tags
-
Rhea-AI Summary
Mirion (MIR) CEO and CFO to present at Citi's 2024 Global Industrial Tech and Mobility Conference. Webcast details provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.42%
Tags
conferences
Rhea-AI Summary
Mirion (MIR) will release financial results for Q4 and full year 2023 on February 13, 2024, followed by a conference call on February 14, 2024, to discuss the results. Participants can access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until February 28, 2024. An archived replay of the call will also be available on the Investors portion of the Mirion website at https://ir.mirion.com/.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.07%
Tags
-
Rhea-AI Summary
Mirion Technologies (NYSE: MIR) has entered into an agreement with TerraPower to design and fabricate key components for the Molten Chloride Reactor Experiment (MCRE), the world’s first critical fast-spectrum salt reactor. This collaboration aims to advance sustainable, low-carbon energy solutions. The MCRE, part of the U.S. Department of Energy’s Advanced Reactor Demonstration Program, will inform the design of TerraPower’s Molten Chloride Fast Reactor (MCFR). Mirion will supply a custom-built MCRE Nuclear Instrumentation System (NIS) to protect the reactor’s core and monitor its neutronic condition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.64%
Tags
none
-
Rhea-AI Summary
Mirion, a global provider of radiation detection solutions, announced Q3 2023 results. Revenues increased 18.8% to $191.2 million, net loss was $12.1 million, and adjusted EBITDA was $38.8 million. The company closed the acquisition of ec2 Software Solutions for $33 million. Full-year 2023 guidance was reiterated.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.2%
Tags
Rhea-AI Summary
Mirion (NYSE: MIR) has partnered with RAD-AID International to bring radiology and radiation safety education to underserved populations worldwide. Mirion made an in-kind donation to RAD-AID's Medical Physics Program, supporting healthcare efforts in several countries. Mirion's solutions, including dosimeters and ultrasound and CT phantoms, will be used to train and educate medical professionals on radiation exposure measurement and quality assurance programs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
partnership
Mirion Technologies Inc.

NYSE:MIR

MIR Rankings

MIR Stock Data

2.42B
148.57M
0.63%
90.45%
3.15%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
US
New York

About MIR

mirion technologies is a provider of radiation detection, measurement, analysis and monitoring products and services to the nuclear power, medical, military and homeland security markets. for more than 50 years, mirion's customers have relied on our solutions to protect people, property and the environment from nuclear and radiological hazards. mirion has facilities in europe, asia, and north america and is headquartered in the san francisco bay area.